Therapeutic Classification: antianginals, antiarrhythmics (class IV), antihypertensives
Pharmacologic Classification: calcium channel blockers
REMS
Absorption: Well absorbed, but rapidly metabolized after oral administration.
Distribution: Unknown.
Protein Binding: 7080%.
Half-Life: 3.59 hr.
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO | 30 min | 23 hr | 68 hr |
POCD, LA, XT | unknown | 14 days‡ | up to 24 hr |
IV | 25 min | 24 hr | unknown |
‡Maximum antihypertensive effect with chronic therapy.
Contraindicated in:
Use Cautiously in:
CV: peripheral edema, ARRHYTHMIA, bradycardia, chest pain, HF, hypotension, palpitations, syncope, tachycardia
Derm: dermatitis, erythema multiforme, flushing, photosensitivity, pruritus/urticaria, rash, STEVENS-JOHNSON SYNDROME (SJS), sweating
EENT: blurred vision, disturbed equilibrium, epistaxis, tinnitus
Endo: gynecomastia, hyperglycemia
GI: ↑liver enzymes, anorexia, constipation, diarrhea, dry mouth, dyspepsia, nausea, vomiting
GU: dysuria, nocturia, polyuria, sexual dysfunction, urinary frequency
Hemat: anemia, leukopenia, thrombocytopenia
MS: joint stiffness, muscle cramps
Neuro: abnormal dreams, anxiety, confusion, dizziness, drowsiness, dysgeusia, headache, nervousness, paresthesia, psychiatric disturbances, tremor, weakness
Misc: gingival hyperplasia
Drug-drug:
Lab Test Considerations:
IV Administration:
NDC Code